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Introduction to Topic 
Diet has been associated with disease throughout 
history. Prior to the 1940's, diseases such as rickets, 
pellagra, scurvy, beriberi, xerophthalmia, and goiter were 
common throughout the world (1). Societies have evolved, 
however, and nutritional deficiencies are no longer the 
sole nutritional concern. Diseases of dietary excesses and 
imbalances have also become linked to illness and death 
(1). More recently, epidemiologic data have linked many 
trace elements to the incidence of chronic diseases such as 
cancer, coronary heart disease, and hypertension (2). 
However, much of the epidemiologic data have been 
inconclusive and incomplete and more research is 
recommended (2). 
Coronary heart disease has consistently been a leading 
cause of death in America for several decades. More than 
500,000 Americans die of coronary heart disease each year, 
1 million Americans suffer from heart attacks and over 6 
million Americans live with symptoms of coronary heart 
disease. Eleva~ions in plasma lipids and cholesterol 
1 
values are strongly associated with the development of 
coronary heart disease (3). 
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Both diets low in saturated fat and cholesterol, and 
increased exercise are beneficial in lowering plasma lipids 
(4). However, other dietary factors including trace 
minerals may also affect plasma lipids and lipoprotein 
profiles. Low intakes of several minerals, including 
copper, zinc, and chromium have been implicated in the 
incidence of coronary heart disease (5-7). These minerals 
may have potential for lowering heart disease risk. This 
is of great importance because trace mineral intakes are 
low in typical American diets (8). However, no currently 
published research has dealt with effects of the 
interrelationship of these minerals on plasma lipids. 
Osteoporosis and age related bone loss are also common 
afflictions, particularly in the elderly population (9,10). 
Much of the research in this area has focused on low 
intakes of dietary calcium andjor vitamin D as the major 
contributing factor (9,11). However, additional nutrients, 
including trace minerals are related to bone loss and have 
an impact on bone mineral content (11}. 
Significance of the Problem 
In 1975, Klevay began investigating correlations 
between the trace mineral status of zinc and copper and 
coronary heart disease incidence (5). Zinc and copper are 
antagonistic for absorption (12), and a higher zinc intake 
3 
relative to copper may suppress copper absorption resulting 
in hypercholesterolemia induced by copper deficiency (13). 
Klevay theorized that a high zinc to copper ratio 
contributed to hypercholesterolemia, and therefore 
increased the risk of coronary heart disease (5). 
Independent copper deficiency also is recognized as a 
causal agent in the precipitation of hypercholesterolemia 
(13). Copper deficiency has been reported to increase 
plasma cholesterol concentrations from 30% to as high as 
185% (13). Copper deficiency also has been reported to 
increase tissue cholesterol concentrations and decrease 
tissue and organ copper concentrations (5,13-15). 
Zinc also is a trace mineral that appears to have an 
effect on plasma cholesterol values (16). This effect, 
however, as previously discussed, has been attributed to 
copper deficiency induced by excessive zinc intake. A 
human study investigating the effect of excessive zinc 
supplementation (300 mg zinc per day), reported an increase 
in low density lipoprotein (LDL) cholesterol and a decrease 
in high density lipoprotein (HDL) cholesterol (16). 
Moderate zinc intakes also may affect plasma cholesterol. 
Moderate zinc intakes in humans (50-75 mg zinc per day) 
also have been reported to depress HDL cholesterol (16). 
In this study serum copper concentrations were not 
significantly affected by zinc intake, thus indicating that 
the effect of zinc intake on plasma cholesterol may be 
independent of copper status. 
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In addition, dietary chromium also may influence serum 
cholesterol concentrations. Chromium deficiency in rats 
has resulted in increased serum cholesterol values, and 
chromium supplementation in various forms has returned 
serum cholesterol values to normal (17,18). "Controlled" 
human studies have shown decreases in serum cholesterol 
concentrations and higher HDL levels upon supplementation 
with chromium-rich yeast (19,20). 
A recent study using rabbits as the experimental 
animal also illustrated an effect of chromium on 
cholesterol concentrations (19). In this study, the 
rabbits consumed chromium in their water in the form of 
potassium chromate or chromium chloride. The chromium-
treated rabbits had a significantly lower cholesterol 
concentration "per-unit length of aorta," in comparison 
with the non-chromium treated rabbits. 
The potential influences of trace mineral intakes on 
plasma cholesterol are numerous and diverse. Dietary fat 
consumption is no longer the singular etiological link to 
cholesterol values. Regulation and metabolism of 
cholesterol is far more complex than once thought. 
In addition to the increased recognition of 
associations between trace minerals and disease states, 
tissue and bone mineral concentrations may also provide 
valuable information in regard to diagnosing and assessing 
deficiency and disease states. Copper is an important 
I 
factor in osteoporosis (10). Copper deficiency and the 
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resultant lysyl oxidase deficiency are responsible for 
defects in collagen and elastin which leads to connective 
tissue abnormalities (10). Osteoporosis is the probable 
consequence. Assessment of tissue and bone copper 
concentrations could be valuable in interpreting the extent 
of this condition. However, the inadequacy of knowledge 
concerning tissue copper concentrations limits the extent 
to which these values can be interpreted (10). Therefore, 
more research in the area of tissue and bone copper 
concentrations and their relationship to disease is 
warranted. 
Zinc also could serve as an indicator or marker, 
providing information on the extent or nature of deficiency 
or disease states. A retrospective study in humans has 
shown positive associations between coronary heart disease, 
acute myocardial infarctions, and plasma zinc 
concentrations (21). Tissue and bone zinc concentrations 
can also provide information about how the deficiency state 
is affecting homeostatic regulation of zinc. Bone is the 
chief reservoir of mobilizable zinc (22). "Low priority" 
tissues such as bone and skin may have zinc mobilized from 
them for use in "high priority" tissues such as the muscle 
and brain (23). Plasma zinc falls when homeostatic 
regulation through tissues such as bone can not be 
maintained (24). 
Tissue and bone chromium concentrations seem to 
provide indicative information about the nature and extent 
of diabetes. In areas where the incidence of maturity-
onset diabetes and atherosclerosis are high, tissue 
6 
concentrations 9f chromium tend to be lower (25). This may 
be of importance because some individuals with inadequate 
chromium intake exhibit diabetes-like symptoms (26). In 
addition, chromium supplementation may improve glucose 
I 
control in subjects with marginal chromium status or in 
insulin resistant subjects (27,28). Therefore, analysis of 
tissue chromium could provide valuable information as to 
the nature of diabetes-like conditions. 
Objectives 
The objectives of this research are to investigate the 
effects and interactions of three trace minerals (copper, 
zinc, and chromium) on plasma lipids (total cholesterol, 
LDL-cholesterol, HDL-cholesterol, and triglycerides), 
plasma glucose, tissue (liver and spleen) and bone minerals 
and the maximum,force required to fracture femurs in male 
Japanese quail. : 
Hypotheses 
The following hypotheses were developed for this 
study: 
1. ~here will be no statistically significant 
I 
independent andfor interactive effect(s) of 
' ' 
dietary copper, zinc, and/or chromium on 
plasma lipids (total cholesterol, LDL-
cholesterol, HDL-cholesterol, and 
triglycerides) in male Japanese quail. 
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2. There will be no statistically significant 
independent and/or interactive effect(s) of 
dietary copper, zinc, and/or chromium on 
plasma glucose in male Japanese quail. 
3. ~here will be no statistically significant 
independent and/or interactive effect(s) of 
dietary copper, zinc, and/or chromium on 
liver, spleen, and bone mineral' 
concentrations in male Japanese quail. 
4. There will be no statistically significant 
tndependent and/or interactive effect(s) of 
dietary copper, zinc, and/or chromium on the 
maximum force required to fracture femurs in 
male Japanese quail. 
Limitations 
The rat is,typically not the animal model of choice 
when addressing cholesterol issues because rodents 
genetically have a high level of HDL cholesterol (13). 
Japanese quail are an appropriate small animal model for 
plasma lipid re~earch because they are relatively 
atherosclerotic~and they mature rapidly. However, data 
from animal research cannot be extrapolated directly to 
humans. The quail model has other limitations. Quail are 
I 
very susceptible to bacterial overgrowth in early stages of 
I 
life. This bacterial overgrowth, if not lethal may 
interfere with nutrient requirements and complicate the 
study. 
Format of Thesis 
Chapters III and IV are written in manuscript form 
using the guide for authors for the Journal of Nutrition. 
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CHAPTER II 
REVIEW OF LITERATURE 
This chapter includes a review of the literature on 
copper, zinc, and chromium. The effects of these minerals 
on plasma lipid concentrations and tissue and bone mineral 
concentrations are reviewed. 
Copper 
Copper is an essential element for man. The duodenum 
is the major site for copper absorption (29). The primary 
storage sites are the liver and spleen (29). The liver, in 
most animals, has the highest concentration of copper (29, 
12). The copper content of the entire human body is about 
50 to 120 mg. This amount is usually found bound to 
proteins (12). Serum copper concentrations have been found 
to range from 0.50 mg/1 to 2.2 mg/1 (30). As age increases 
so do copper concentrations (30). 
Copper has numerous functions in the human body. For 
example, it has a role in antioxidation, skeletal 
integrity, glucose metabolic regulation, and myelin 
formation (31,32). The estimated safe and adequate daily 






Copper Deficiency and Lipids 
Copper is more recently known for it's influence on 
heart disease. Copper deficiency has been implicated in 
the development of hypercholesterolemia (33) and may play 
an important role in cardiovascular system integrity (31). 
Animal in vivo studies have demonstrated that 
hypercholesterolemia is associated with copper deficiency 
(15,33,34). This marked elevation in cholesterol is 
attributed to increases in different lipoproteins and 
subfractions (33-37). Allen and Klevay (33), although 
noting an increase in both high density lipoprotein-
cholesterol and low density lipoprotein-cholesterol, 
observed a significant relative decrease in the percent of 
plasma cholesterol associated with the high density 
lipoproteins (HDL) in copper-deficient rats. They observed 
that high density lipoprotein-cholesterol increased 85%; 
however, when the HDL-bound cholesterol was expressed as a 
percentage of t~tal plasma cholesterol concentration there 
was a 9.6% decrease (33). The bulk of the 
hypercholesterolemia observed came from a 187% increase in 
plasma low density lipoprotein-cholesterol. 
Harvey and Allen (34) also noted a decrease in plasma 
HDL-cholesterol associated with copper deficiency in rats. 
The cholesterol in this fraction decreased by 17% and 12% 
when compared to ad libitum and pair-fed controls, 
respectively. More specifically, the percent cholesterol 
esters in the HDL fraction was significantly decreased, 
1 1 
while a significant increase in the free cholesterol in HDL 
was observed. In contrast, very low density lipoproteins 
{VLDL) and low density lipoproteins {LDL) were 
characterized by a significant decrease in free cholesterol 
and a significant elevation in the percent of cholesterol 
esters. The total cholesterol from VLDL and LDL in the 
copper deficient animals increased 184% compared to pair 
fed controls and 203% compared to ad libitum controls. 
Copper deficiency essentially reversed the normal HDL/{VLDL 
+LDL) cholesterol ratio of 2:1 in copper adequate rats 
{34). Harvey and Allen {34) attributed the differences 
between the observed decrease in HDL cholesterol and the 
observed increase in HDL cholesterol by Allen and Klevay 
{33) to the different durations of the studies. However, 
both studies observed significant increases in 
triglycerides. A 252% increase in the plasma triglyceride 
concentration was observed by Allen and Klevay {33) and 
188% and 195% increases in triglycerides were observed 
between copper-deficient rats and the pair-fed and ad 
libitum controls by Harvey and Allen {34). 
Croswell and Lee {36) found increases in all 
lipoprotein levels in copper-deficient rats with the 
largest increases occurring in very low density lipoprotein 
{VLDL) and low density lipoprotein {LDL) fractions. 
Lefevere and co~workers {37) also noted a large increase in 
plasma total cholesterol of copper-deficient rats. 
However, they attributed the hypercholesterolemia in copper 
12 
deficiency to selective increases in HDL cholesterol. They 
did not observe a difference in VLDL cholesterol and LDL 
cholesterol or triglycerides between control and copper-
deficient rats. Additionally, Lee and Koo (35) also 
observed an increase in total cholesterol with a marked 
increase in the HDL fraction among copper-deficient rats. 
Conflicting findings have been reported (35-37) on the 
effect of copper deficiency on HDL subclasses. Lee and Koo 
(35) concluded that the hypercholesterolemia they observed 
was primarily due to an increase in the HDL subfraction 
that contained large amounts of apolipoprotein A-I (Apo A-
I) but contained no apolipoprotein E (Apo E). Croswell and 
Lei (36), in contrast, attributed the hypercholesterolemia 
induced by copper deficiency to increases in cholesterol 
and apolipoprotein contents of the Apo E-rich HDL; however 
Apo A-I concentrations were also significantly higher in 
copper-deficient rats compared to copper-adequate controls 
(36). Lefevere and co-workers (37) also found 
significantly higher Apo A-I levels in the HDL fractions of 
copper-deficient rats than in control animals. 
Additionally, Apo E-rich fractions also increased but did 
not reach significance (37). 
Induced hypercholesterolemia, by the addition of 0.50% 
cholesterol and 0.25% cholic acid, in rats has been shown 
to decrease or disappear with copper supplementation (38). 
This modification of hypercholesterolemia occurred late in 
the experiment. When the level of added cholesterol and 
cholic acid was reduced to 0.20% and 0.10%, respectively, 
the addition of dietary copper was sufficient to restore 
liver copper concentrations from decreased levels. 
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In humans, similar copper deficiency effects have been 
observed (39). In one study of a healthy man with induced 
copper depletion, significant increases in total and low 
density lipoprotein cholesterol levels were observed (39). 
Although ceruloplasmin, plasma copper, and superoxide 
dismutase were sensitive indicators of copper status, lipid 
changes were more sensitive to copper depletion than 
hematological measurements, including hemoglobin, 
hematocrit, mean corpuscular volume, and plasma iron 
measurements (39). 
Other factors appear to affect the severity of lipid 
changes with copper deficiency (40-42). Fructose as the 
primary carbohydrate in the diet seems to increase the 
requirement for copper and augments copper deficiency (41). 
However, this effect was not observed with sucrose (42). 
Both aspirin intake (40) and beer consumption {15) 
mitigated some of the effects of copper deficiency, 
resulting in lower plasma cholesterol concentrations and 
more appropriate tissue copper concentrations. 
Excessive Copper and Lipids 
Although copper deficiency is linked to 
hypercholesterolemia, elevated serum copper concentrations 
are a risk factor for ishemic heart disease {30). Men in 
14 
Eastern Finland, as a population, have been observed to 
have elevated serum cholesterol concentrations. This 
elevation has been attributed to high serum copper 
concentrations. An abundance of dietary copper in the soil 
and drinking water has been identified as a possible cause. 
It has been hypothesized that the increased copper intake 
acts to interfere with the absorption of selenium which is 
inversely associated with cardiovascular disease risk (30). 
Thus, both copper excesses and deficiencies have been 
correlated with increased risk of heart disease. 
Copper and Tissue Minerals 
Tissue trace mineral concentrations are often used to 
assess dietary adequacy and decreased tissue concentrations 
are often concomitant with copper deficiency and altered 
lipid concentrations (15,34-40,43). Depressed body weights 
and increased tissue weights relative to body size also 
accompany changes in lipid concentrations and illustrate 
the extent of copper deficiency. More specifically there 
is usually an impaired weight gain (35,36) and an 
enlargement of the heart (35-37). Lee and Koo (35) 
observed significantly lower body weight gains in copper-
deficient rats compared with copper-adequate controls after 
ten weeks. Enlarged liver weights as a percentage of body 
weight were also observed (34,35). Plasma copper 
concentrations have been observed to decrease in copper 
deficiency (35,37), sometimes to half that of control 
15 
animals {37). Hepatic copper concentrations also decrease 
markedly with copper deficiency {34-37). Hepatic zinc 
concentrations appear to correlate with hepatic copper 
concentrations {41,43). 
Copper supplementation seems also to have an effect on 
tissue minerals. Tissue concentrations have been observed 
to increase with copper administration {44). However, 
factors such as the form of copper and the protein 
component of the diet are influential. Chicks fed 150, 
300, or 450 mg copper/kg diet either as reagent grade 
acetate or feed grade carbonate or sulfate had 
proportionally increased liver copper concentrations (44). 
Dietary copper from the oxide source did not significantly 
affect liver copper. The copper source did not influence 
bone copper, however, bone copper concentrations were lower 
in chicks fed 150 mg of copper/kg diet compared to other 
dietary levels (44). Differences in tissue accumulation of 
copper with different protein components have also been 
observed (45). Tissue copper accumulation was lower in 
chicks consuming a corn-soybean meal complex diet than in 
chicks fed a casien-dextrose semi-purified diet (45). 
Copper and Bone 
Copper deficiency and the resultant lysyl oxidase 
deficiency primarily affect the development of bone by 
contributing to the inadequate cross-linking of collagen 
and elastin {10). The connective tissue abnormalities that 
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are caused by the lysyl oxidase deficiency lead to 
osteoporosis (10). The inadequacy of knowledge about 
copper sources within tissues, the exchange of copper 
between tissues, and recycling of tissue copper interferes 
with interpretation of tissue mineral analyses {10). The 
information available about bone copper concentrations is 
limited and the topic needs further research. 
In Vitro Copper-Mediated LDL Oxidation 
In vitro copper mediates oxidation of LDL (46,47). 
Kalyanaraman et al. hypothesized that formation of a 
copper-LDL complex is crucial to copper oxidation of LDL 
(48). Oxidized LDL is more susceptible to degradation and 
uptake by macrophage foam cells (46,47). Oxidized LDL is 
taken up by a macrophage scavenger receptor pathway (49). 
Pure macrophage-derived foam cells from atherosclerotic 
rabbit aortas (46), mouse resident peritoneal macrophages 
(47), 5 uM cuso4 (47), and endothelial cells from human 
arteries, veins, and microvessels (50), all modify LDL. 
Modification and oxidation of LDL often induce changes in 
the LDL particles including increased electrophoretic 
mobility {50-52) and buoyant density of the LDL particles, 
as well as altered lipid composition of LDL {50). 
Thiobarbituric acid reactive substances are also generated 
{51,53,54). Immunoreactive apolipoprotein B {55}, or apo B 
100 {53,56), undergoes fragmentation (52,53,55,56) and 
disappears during oxidation of LDL {55). The formation of 
17 
hydroperoxides and depletion of endogenous alpha-tocopherol 
also occur with LDL oxidation (56,57). Higher 
protein/cholesterol ratios in LDL are also seen with LDL 
oxidation (58). 
Lipid hydroxy and hydroperoxy derivatives also 
increase with copper oxidized LDL (51). These increases 
occur as linoleate (18:2) and arachidonate (20:4) decrease 
in oxidized LDL (51). These decreases were observed after 
a 4-6 hour period. Thomas and Jackson (54) found that 
trace amounts of lipid hydroperoxides in the lipoprotein 
were required for the initiation of copper dependent 
oxidation. 
Yia-Herttuala and co-workers (59) observed that lesion 
LDL was similar to oxidized LDL indicating that 
atherosclerotic lesions may contain oxidized LDL. They 
found increased electrophoretic mobility, a higher density, 
a higher free cholesterol content, and the presence of 
apolipoprotein B fragments in the lesion LDL. The lesion 
LDL was degraded more rapidly than plasma LDL. A 
subfraction of plasma LDL, equal to 1% of total plasma LDL, 
has similar properties to oxidized LDL in that it has an 
increased negative charge, a higher protein/cholesterol 
ratio, and a higher density than LDL (58). This may be 
associated with oxidation of LDL and atherosclerotic 
changes. 
superoxide dismutase prevents transition metal-induced 
lipid peroxidation changes (50,53). Hindsberg and 
18 
colleagues (50) also noted variation in the degree to which 
LDL from various donors could be modified. Diet and 
lipophylic antioxidants have been hypothesized as 
contributing to this variation (50). Free radical 
scavengers, such as butylated hydroxytoluene and butylated 
hydroxyanisole, also inhibited copper-mediated modification 
of LDL in monkey smooth muscle cells (60). Flavonoids 
conserved the endogenous alpha-tocopherol content of LDL, 
postponed lipid peroxidation, and inhibited cuso4 mediated 
oxidation of LDL (57). The 4-6 hour lag period noted with 
LDL modification (47,57) might be due to the alpha-
tocopherol content of LDL. The alpha-tocopherol is 
depleted during this time (57). Alpha-tocopherol can only 
inhibit oxidated modification of LDL for 5 hours (61). 
Ascorbate also has an inhibitory effect but for a longer 
duration of 24 hours (61). The decreased electrophoretic 
mobility and thiobarbituric acid reacting substances, as 
well as the decreased uptake by macrophage scavenger 
receptors show the extent of the inhibitory effects on cell 
free oxidation. Saito and colleagues (62) showed that 
rabbits fed purified eicosapentaenoic acid yielded LDL that 
was somewhat resistant to oxidative modification by copper 
in comparison to control animals. 
HDL interferes with LDL modification (50,63). 
Although HDL inhibits macrophage degradation of oxidized 
LDL, it did not affect the thiobarbituric acid reacting 
substances nor did it affect the electrophoretic mobility 
of oxidized LDL (63). 
Zinc 
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Zinc is essential for optimal health as it is 
associated with biological functions of growth, wound 
healing, and the regulation of zinc containing enzymes 
(64). With the functional emphasis of zinc centering 
around tissue synthesis and repair, it is alarming that the 
two groups at risk for low zinc intake are older women and 
two year old children (8). Zinc status is dependent upon 
three factors; homeostatic regulation (64), bioavailability 
(26), and interactions with other dietary factors (26,64). 
An individual's zinc requirement depends on hisjher zinc 
status and body pool of usable zinc (64). This body pool 
is small and undergoes rapid turnover (26,64), as can be 
seen by the rapid onset of deficiency symptoms as well as 
the quick restoration to a zinc-adequate state (64). Zinc 
is more efficiently used by people with compromised zinc 
status than by persons with an adequate body pool of zinc 
( 26) . 
Bioavailability of zinc varies widely among food items 
(26). Animal products account for 70% of zinc consumption 
in the United States (26). Meat, liver, seafood, eggs, and 
dairy products are good sources of zinc (26). Whole grain 
sources of zinc are less available. Total calorie intake, 
protein, fiber, phytates, calcium, phosphorus, and iron all 
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may interfere with zinc absorption and utilization (26,64). 
Typical diets of North American adults seem to be adequate 
with consumption patterns of zinc ranging from 10-15 mgfday 
(26). Balance studies show a need for at least 12 mgfday 
of zinc and the RDA for zinc has been set at 12 mgfday for 
women and 15 mgfday for men (26). Although zinc is 
absorbed in both the small and large intestine, absorption 
occurs primarily in the duodenum (64). Competition for 
absorption between copper and zinc can occur in the 
intestinal lumen (65). If the luminal concentration of one 
of these minerals is high, inhibition of the other 
mineral's absorption ensues (65). 
Loss of appetite, growth retardation, skin lesions, 
immunological abnormalities, and reproductive impairment 
are common signs and symptoms of zinc deficiency in humans 
(26,64). In Japanese quail, inadequate feathering and 
skeletal abnormalities are observed with zinc deficiency 
( 64) • 
Zinc Deficiency and Lipids 
Hypocholesterolemia has been observed with zinc 
deficiency in both humans and animals (66), primarily due 
to decreases in HDL cholesterol (66,67). This finding is 
important because of the inverse association between HDL 
cholesterol and coronary heart disease (66). Thus, 
marginal zinc intake could serve as a risk factor in terms 
of cardiovascular health (66). Schneeman and colleagues 
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(67) observed a decrease in HDL-cholesterol concentrations 
in zinc-deficient rats, as well as a decrease in VLDL-
triglycerides. However, they attributed these changes to 
reduced food intake, common in zinc deficiency. Koo and 
Williams (66), in contrast, observed significant decreases 
in total serum cholesterol, HDL-cholesterol and 
triglycerides in zinc-deficient rats compared to pair-fed 
controls. A significant decrease in serum zinc 
concentration was also observed; however, serum copper was 
not affected (66). Schneeman and co-workers (67) found no 
significant difference in HDL parameters between zinc-
deficient animals and restricted-intake controls. In a 
more recent study, Koo and Lee (68) found that zinc 
deficiency in rats significantly lowered the concentration 
I 
of actual circulating HDL particles; concentrations 6f 
total protein, triglycerides, phospholipids, and 
cholesterol were not affected. Koo and Lee (68) 
hypothesized the younger age of the animals or the 
extremely low zinc level (0.4 mgfday) in the zinc-deficient 
diet could explain the conflicting results between their 
studies. Age-related changes have been observed in plasma 
HDL (68). 
Koo and Lee (68) also observed changes in the HDL 
apolipoprotein profile with marginal zinc deficiency. They 
reported an increase in Apo A-I and decreases in the , 
relative proportions of Apo E and Apo c. Lefevere et al. 
(69) did not observe a decrease in plasma HDL-cholesterol 
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concentrations or in HDL-apolipoprotein concentrations in 
zinc-deficient rats. However, HDL tended to have increased 
free cholesterol and decreased triglycerides (69). In 
addition, a significant decrease in HDL Apo c 
concentrations was observed. In a subsequent study, Koo 
and Lee (70) observed a decrease in circulating HDL 
particles containing no Apo E in zinc-deficient rats. Apo 
A-I and Apo C concentrations were also decreased in the 
plasma (70). 
In addition to the alterations in the lipoprotein and 
apolipoprotein profiles, impaired absorption of dietary 
lipids with zinc deficiency (71) has also been observed in 
rats, as well as delayed plasma clearance of chylomicron 
cholesterol (72,73). Koo and colleagues (72) attributed 
this delayed clearance to morphological changes in the 
chylomicron and altered chylomicron apolipoprotein 
composition rather than impaired chylomicron synthesis. 
The increased chylomicron size may delay hepatic removal 
and decrease hepatic synthesis and release of cholesterol 
(72). Apo B content of lymphatic chylomicrons was 
significantly lower in zinc-deficient rats compared to 
controls (71). 
Excessive Zinc and Lipids 
Human dietary zinc intakes between 100 and 300 mg 
zinc/day are considered pharmacological doses and may 
result in a wide range of symptoms and disorders. Copper 
deficiency characterized by anemia, hypocupremia, 
leukopenia, and neutropenia, in addition to an impaired 
immune function, and alterations in serum cholesterol and 
lipoprotein profiles are complications associated with 
excessive zinc intake {16). 
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Extreme zinc intakes in rats are associated with an 
increase in serum cholesterol (16). In humans, increased 
LDL concentrations have been observed, while HDL 
concentrations decrease with excessive zinc (16). Chandra 
(74) observed a significant decrease in HDL concentrations 
of eleven healthy men supplemented with 150 mg zinc/day and 
a slight elevation of LDL which overall resulted in a 
marked rise in the LDL/HDL ratio. Samman and Roberts (75), 
in contrast, did not observe any significant effects in 
males on lipoprotein profiles or copper indices with 
excessive zinc supplementation. However, they did observe 
a significant 9% decrease in LDL cholesterol in females 
with daily supplementation of 150 mg zinc for 12 weeks. 
HDL-cholesterol was redistributed with a slight increase in 
HDL-2 and decrease in HDL-3 subfractions (75). HDL-2 is 
positively associated with a lower risk of coronary heart 
disease (75). Ceruloplasmin and erythrocyte superoxide 
dismutase activity were decreased in the women 
participants, possibly illustrating a compromised copper 
status (75). However, total plasma mineral concentrations 
in these studies did not change for either males or 
females. The lack of response in men could be due to a 
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gender difference. However, Samman and Roberts (75) 
support the view that the differences between gender could 
be dose related, since the women, although weighing less, 
received the same dose of 150 mg zincfday. 
Freeland-Graves et al. (76} observed a transient 
decrease of HDL cholesterol in women supplemented with 100 
mg zincfday. HDL-cholesterol decreased by 8.4% during the 
4th week of the experiment and returned to normal values by 
the 6th week of the experiment (76). Plasma zinc values 
peaked during the 4th week of the experiment and 
subsequently declined toward initial values. Freeland-
Graves and colleagues postulated that certain plasma zinc 
values need to be maintained in order to observe HDL 
alterations (76). 
Moderately excessive intakes of zinc also have been 
observed to affect cholesterol concentrations (77,78). 
Black et al. (77) investigated the effects of zinc 
supplements at 50 and 75 mgfday for twelve weeks in humans. 
They observed a significant decrease in HDL-cholesterol 
concentrations, at weeks six and twelve in males 
supplemented with 75 mg zinc/day as zinc gluconate compared 
to placebo subjects. HDL concentrations at weeks 6, 8, and 
12 were also significantly lower than baseline values. 
Those males receiving supplements Qf 50 mg zincfday had 
significantly lower HDL-cholesterol concentrations at week 
twelve compared to baseline values or twelve week HDL-
cholesterol concentrations of the placebo group (77). 
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However, Freeland-Graves et al. (76) observed no plasma 
cholesterol alterations with moderate supplementation (15 
or 50 mg zincfday) in men. Crouse and colleagues (79) 
monitored plasma cholesterol concentrations of sedentary 
and endurance-trained men during eight weeks of low dose 
zinc supplementation (50 mg zinc/day). They did not 
observe any changes in total cholesterol, HDL-cholesterol, 
LDL-cholesterol or triglyceride concentrations (79). 
Brewer and co-workers (80) looked at the long-term effects 
of zinc supplementation (2 years) in Wilson's disease 
patients. Zinc therapy combats the excessive copper levels 
of Wilson's disease by induction of intestinal cell 
metallothionein, blocking intestinal copper absorption 
(80). In this study they reported that zinc therapy 
reduced total cholesterol by about 10% in males and females 
and reduced HDL-cholesterol by about 20% in males (80). 
Cho et al. (78) noted a significant decrease in serum HDL-
cholesterol in rats upon short term {5 days) 
supplementation with 40 mg zinc/kg. Zinc-supplemented 
animals had decreased cholesterol-induced liver 
peroxidation and damage. 
In normal subjects and subjects with compromised 
health, the zinc-induced derangement of copper metabolism 
has been viewed as an influential factor in lipid and 
lipoprotein regulation {5,16). Human cholesteryl ester 
transfer protein {CETP) may be another vehicle by which 
zinc influences cholesterol metabolism {81). This protein 
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facilitates the exchange of neutral lipids between 
lipoproteins (81). Additional zinc in the drinking water 
of CETP transgenic mice resulted in an increase of the CETP 
mRNA in the small intestine and liver, indicating that zinc 
can induce the expression of that transgene. Plasma CETP 
levels rose by 140% when, 10 mM of znso4 was supplemented in 
the drinking water for 3 days and by 200% when 25 mM znso4 
was administered in the drinking water for 7 days. This 
zinc-induced expression of the CETP transgene resulted in a 
significant decrease in total plasma cholesterol, 
specifically due to decreases in plasma HDL-cholesterol 
(81). 
Zinc and Plasma and Tissue Minerals 
Zinc deficiency contributes to restricted food intake 
in animals (67). Significant decreases in body weights 
have been observed in zinc-deficient animals compared to 
pair fed-controls (67-72). In addition, liver and plasma 
zinc concentrations are significantly decreased in zinc 
deficiency (67-69,72). Plasma zinc concentrations have 
been observed to increase significantly with zinc 
supplementation (74-76). Black et al. (77) observed 
transient increases in serum zinc concentrations in adult 
males supplemented with 50 mg zinc/day. Supplementation of 
75 mg zinc/day resulted in increased serum zinc throughout 
the 12-week study (77). Crouse and colleagues (79) 
observed a 15% increase in plasma zinc concentrations among 
zinc supplemented males and a 0.4% zinc increase in the 
placebo group; (however, this increase in plasma zinc did 
not reach statistical significance. Cho and co-workers 
(78) observed increases in both serum and liver zinc 
concentrations in zinc-supplemented rats. 
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In a retrospective study of patients with acute 
myocardial infarction (AMI) and coronary heart disease 
(CHD), a significant increase in plasma zinc concentrations 
was observed (21). Elevated plasma zinc was believed to 
interfere with the lecithin:cholesterol acyltransferase 
(LCAT) reaction in these AMI and CHD patients. 
Significantly decreased LCAT activity may have importance 
as a risk factor for CHD (21). 
Zinc and Bone Minerals 
Bone mineral content as well as tissue mineral 
concentrations serve as indicators or markers, providing 
information on the extent or nature of a deficiency or 
disease state. 
Zinc intake was observed to be significantly 
correlated with changes in mineral content of the radius in 
post-menopausal non-supplemented women between the ages of 
35-65 years of age (11). Excessive dietary zinc retarded 
bone resorption and differentiation in pigs fed high-zinc, 
low-copper diets (82). Zinc-deficient guinea pigs had 
significantly lower plasma and bone zinc concentrations 
than zinc-adequate controls (22). In this study, bone 
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served as the chief reservoir of mobilizable zinc; 
significant decreases in zinc concentrations of soft 
tissues such as muscle, brain, liver, or skin were not 
observed (22). In a zinc-deficient rabbit study, however, 
bone zinc concentrations decreased by 45% while liver zinc 
decreased by 20% and skin zinc concentration decreased by 
35% (23). Bone and skin may be "low priority" tissues that 
mobilize zinc for the "high priority" tissues such as the 
muscle and brain (23). 
Both in laboratory animals and in humans it appears 
that zinc concentrations are compromised in the bone, 
liver, testes, and plasma to maintain normal zinc 
concentrations in other tissues such as muscle (24). 
Plasma zinc falls when homeostatic regulation through 
tissues such as bone can not be maintained (24). The 
reduction in growth, possibly through decreased food 
intake, allows animals to maintain a normal whole body zinc 
concentration and may be a survival mechanism (24). Weight 
gain in zinc-deficient rats stimulates zinc depletion due 
to decreased protein catabolism and increased anabolism 
(83). Park et al. (83) found that zinc-depleted force-fed 
rats could not survive beyond 8-10 days. The increased 
zinc requirement during anabolism and the animals' 
inability to regulate growth and skeletal mass via reduced 
food intake brought about the rapid results. Bone zinc 
seems to correlate with zinc intake while lower liver zinc 
correlated with undernutrition (84). 
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Chromium 
Chromium, also, is an essential element for animals 
and humans (25). Chromium is a transition element that 
occurs in eight oxidation states (25). The most common 
oxidation states are o, +2, +3, and +6 (25). The trivalent 
state is the most stable (85), and is required for 
maintenance of normal glucose metabolism (26). Chromium 
must be in a biologically active form in order to perform 
its physiological functions (25). The biologically active 
form of chromium has been isolated from brewer's yeast and 
the yeast possibly contains nicotinic acid, glycine, 
glutamic acid, and cysteine, in addition to chromium (25). 
The precise arrangements and composition of the structure 
remain undefined and controversial (25). These amino acids 
and nicotinic acid have demonstrated biological activity 
when synthetically arranged in chromium complexes (25). 
Glutathione, chromium, and nicotinic acid complexes also 
have demonstrated biologically active properties (25). 
Although intestinal absorption of chromium is low 
(85), it appears that it is primarily absorbed in the 
jejunum (25). Chelation and mineral interactions influence 
chromium's absorption (25,85). Oxalate increases chromium 
absorption, while phytate, to a lesser extent, decreases 
absorption through chelation (25,85). Chromium and iron 
may share a transport mechanism; intestinal concentrations 
of iron either promote or interfere with chromium 
absorption. Iron-deficient animals absorb more chromium in 
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comparison with iron-supplemented animals. When oral iron 
was administered to the iron-deficient animals, chromium 
absorption was inhibited (25). Zinc in a similar manner 
influences chromium absorption; oral zinc decreased 
chromium absorption while chromium decreased zinc 
absorption (25). Once absorbed, trivalent chromium appears 
to be transported to the tissues primarily by transferrin 
(25) • 
Chromium consumption in typical western diets ranges 
between 25 ug chromium/day to 200 ug chromium/day, with 
most intakes below 100 ugfday (26). These levels could be 
a cause for concern because only 1% of oral chromium is 
absorbed (25). An estimated safe and adequate range has 
been established between 50 and 200 ug of chromium/day 
(26). At intakes near the lower end of the range; 50 ug of 
chromium/day, no signs or symptoms of chromium deficiency 
develop (26). Chromium intake reaching the upper end of 
the range; 200 ug chromium/day, over a period of time also 
has shown no adverse signs. In a varied diet providing an 
adequate intake of other micronutrients, chromium 
absorption averages 0.5% (26). In general, the more 
unprocessed and fibrous the food is, the higher it will be 
in chromium content (7). Mushrooms, brewer's yeast, 
prunes, asparagus, rhubarb, black pepper, wine, and beer 
are foods high in chromium (7). The bioavailability of 
chromium in calf liver, American cheese, and wheat germ 
also make these products good sources of chromium (26). 
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Chromium and Glucose 
Chromium's physiological role in animals and humans 
centers around regulation of glucose metabolism through 
insulin potentiation (7,25,85). Glucose breakdown can be 
increased by the addition of the biologically active 
chromium; in contrast, more insulin is needed at suboptimal 
chromium levels (7). Diabetes-like symptoms may occur in 
some individuals with inadequate chromium intake (26). 
Chromium supplementation studies are conflicting 
regarding chromium's role in glucose metabolism. The 
biologically active form of chromium in brewer's yeast 
along with the nicotinic acid, glutamic acid, glycine, and 
a sulfur containing amino acid is known as the glucose 
tolerance factor (85). It is unclear how much of 
chromium's influence on insulin and glucose regulation is 
due to the chromium itself or due to chromium complexes 
such as the glucose tolerance factor (20,86). In addition, 
many studies have reported that chromium supplementation 
benefits only those with marginal chromium status or those 
who are insulin resistant (27, 28). 
Chromium and Lipids 
Marginal chromium status also has been implicated as a 
risk factor for atherosclerosis and altered lipid 
metabolism (7). Elevated insulin concentrations, seen with 
suboptimal chromium status have been associated with the 
incidence of coronary heart disease (7). However, 
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comparison of the inhibitory effects of low chromium and 
high chromium derived fractions on liver cholesterol 
synthesis in vitro concluded that chromium compounds do not 
appear to account for the inhibitory effects of brewer's 
yeast (87). 
Offenbacher and Pi-sunyer (20) investigated the 
effects of 9 grams of chromium-rich brewer's yeast on serum 
glucose, insulin, cholesterol, total lipids, and 
triglycerides in both diabetic and nondiabetic elderly 
subjects. Elderly subjects supplemented with 9 grams of 
chromium-poor torula yeast served as controls. Glucose 
tolerance improved significantly in the experimental group. 
In addition to a decreased insulin output, serum total 
cholesterol, and total lipids were significantly lower in 
the brewer's yeast-supplemented group compared to the 
controls. However, a significant decrease in serum total 
cholesterol of nondiabetic participants in the chromium-
poor torula yeast-supplemented group also was observed 
(20). This suggests that there may be another factor in 
yeast contributing to the cholesterol lowering effect (20). 
In a subsequent study, Offenbacher et al. (88) examined the 
effects of a 10 week supplementation study with 5 grams of 
brewer's yeast or 200 ug of trivalent chromium as chromium 
chloride in free-living elderly subjects. Glucose 
tolerance, plasma insulin, cholesterol, and triglycerides 
did not change significantly in either of the two 
experimental groups, compared to the placebo group (88). 
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Plasma insulin output did decrease slightly in both the 
brewer's yeast and the chromium chloride groups after a 
glucose load. The brewer's yeast group exhibited decreased 
insulin output 45 and 90 minutes after the glucose load, 
while insulin output of the chromium chloride group 
decreased 45 minutes post-glucose load (88). However, 
these decreases in glucose load did not reach significance. 
Plasma chromium concentrations increased significantly in 
the chromium chloride group only (88). 
There are some experimental details between the 
studies which may explain the descrepancies. One possible 
explanation is that the supplement in the later study 
provided too little chromium to evoke a response (88). In 
addition, the first study recruited participants from a 
retirement home as opposed to free-living elderly (20). 
The institutionalized nature of the first group could have 
contributed to a suboptimal intake of chromium. The free-
living volunteers in the later study were very well 
nourished, consuming over 100% of the RDA for eight 
indicator nutrients (88). The retirement home elderly who 
exhibited a significant decrease in total serum cholesterol 
and lipids were initially hypercholesterolemic (20). A 
combination of the these factors could explain the lack of 
response from the chromium supplements in chromium adequate 
elderly. 
Vinson and Bose (89) more extensively addressed the 
influence of chromium supplementation on glucose control 
34 
and plasma lipid responses in the following subgroups; 
normal subjects, hyperglycemic subjects, insulin-dependent 
diabetics, and noninsulin-dependent-diabetics for six 
months. Participants consumed 100 mg of yeast daily which 
contained 218 ug of chromium. A transient improvement was 
observed in the percent glycosylated hemoglobin at months 
two and four in the insulin dependent diabetic group (89); 
however, at six months the percent glycosylated hemoglobin 
was close to pre-dose values in this group. The 
hyperglycemic participants averaged a significant 57% 
improvement in blood glucose control at the end of six 
months. The observed improvements in glucose regulation 
were attributed to the actual chromium in the original 
yeast rather than to other components in the yeast. 
Although transient 'improvements in serum cholesterol and 
triglyceride concentrations were observed, no group 
sustained statistically significant improvements in serum 
lipid concentrations after six months of chromium 
supplementation (89). However, participants were not 
subdivided into hypercholesterolemic risk groups (89). HDL 
concentrations were significantly elevated in the 
hyperglycemic group at six months and HDL concentrations 
were also temporarily increased in normal participants 
after two months. The hyperglycemic group was the only 
group after four months that observed a significant 
decrease in serum LDL concentrations as well as a 
significant decrease in the cholesterol to HDL ratio. This 
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group decreased its risk for coronary heart disease by 50% 
by the end of the study (89). 
Anderson et al. (86) observed significantly lower 
fasting glucose concentrations in male and female subjects 
after two months of supplementation with 200 ug of chromium 
as chromic chloride. Again, these values returned to pre-
supplementation concentrations after three months of 
supplementation. However, the effects of chromium 
supplementation on serum glucose varied based on subject's 
90-minute post-glucose challenge glucose concentrations 
(86). Subjects whose 90-minute post glucose values were 
greater than or equal to 100 mg/dL had a significant 
decrease in serum glucose. On the other hand, subjects 
whose 90-minute glucose concentrations were less than or 
equal to fasting levels had a significant increase in serum 
glucose concentrations. Subjects whose 90-minute blood 
glucose were greater than fasting but less than 100 mgfdL 
did not have any significant changes in serum glucose (86). 
Chromium supplementation did not alter any lipid variables 
( 86) • 
Uusitupa et al. (27) did not observe any significant 
improvements in glucose tolerance or serum lipid 
concentrations in noninsulin dependent diabetics after 
supplementation of 200 ug trivalent chromium for 6 weeks. 
However, they did observe a significantly decreased 1-hour 
post-glucose serum insulin level in chromium supplemented 
diabetics as opposed to insulin levels of placebo-treatment 
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diabetics (27), thus indicating that less insulin is 
required at optimal chromium levels. Twenty-four hour 
urinary chromium excretion increased nine-fold upon 
supplementation indicating that subjects were in chromium 
balance (27). Riales and Albrink (28) observed a 
significant increase in HDL cholesterol concentration and a 
decrease in the body weights of human males consuming 200 
ug of trivalent chromium in 5 ml of water, five days a week 
for twelve weeks. A decrease in insulin relative to plasma 
glucose levels also was observed, exhibiting increased 
insulin sensitivity (28). 
Several studies investigating the effect of chromium 
on the formation of atherosclerotic lesions have used 
rabbits as the animal model (19,90,91). Abraham et al. 
(90) observed a 50% reduction in the aortic intimal plaque 
and aortic total cholesterol content in Loewnstein male 
rabbits upon intraperitoneal injection of 20 ug of 
potassium chromate in 0.2 ml distilled water (90). Serum 
total cholesterol, LDL-cholesterol, and triglyceride 
concentrations were lower and HDL fractions were higher in 
chromium-treated rabbits compared to control rabbits, but 
the differences were not significant (90). Flexon and 
colleagues (91) also observed a non-significant decrease in 
serum cholesterol among New Zealand White rabbits injected 
intraperitoneally with 20 ug of potassium chromate in 0.2 
ml of distilled water, five days a week for ninety days. 
However, no significant changes in total cholesterol 
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content per gram of aorta or in the percent intima covered 
with plaque were observed (91). Possible explanations for 
the differences observed between these studies are the 
different rabbit breeds used, differences in initial 
weights resulting in a different dose relative to body 
weight and different methods for determining aortic plaque 
(91). Abraham et al. (19) observed a marked reduction in 
the percent of aortic intimal surface covered by plaque and 
in the cholesterol content of chromium-treated Loewenstein 
male rabbits. The trivalent form of chromium as 20 ug 
chromium chloride elicited a better response than rabbits 
treated with the hexavalent chromium in doses of 10 or 20 
ug potassium chromate (19). 
Donaldson et al. (92) observed a transient increase in 
postprandial plasma glucose concentrations in male rats fed 
a low-chromium (60-100 ug chromium/g diet), high-sucrose, 
high-cholesterol diet at four and eight months when 
compared to control rats fed a chromium-supplemented, high-
sucrose, high-cholesterol diet. No other significant 
changes were observed throughout the 18 month study. 
Donaldson and colleagues (92) suggested that other factors 
aside from dietary chromium could play a part in the 
manifestation of glucose intolerance in this animal model. 
Large inter- and intra- animal variability in glucose 
disappearance rates in young adult rats upon preliminary 
i.v. glucose tolerance tests are examples of such factors 
(92) • 
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Other factors may influence the effect of chromium 
supplementation on lipid concentrations. Stoecker and 
Oladut (93) observed a synergistic effect between chromium 
and ascorbate deficiency. Male Hartley guinea pigs, 
deficient in both ascorbate and chromium, had higher plasma 
glucose concentrations ninety minutes post-glucose load 
than animals receiving adequate ascorbate. They also 
observed a significant relationship between chromium 
depletion and blood cholesterol levels (p<0.0003) (93). On 
the other hand, Cupo and Donaldson (94) found no effect of 
chromium on glucose metabolism or lipid synthesis in chicks 
supplemented with 20 ppm chromium and/or 20 ppm vanadium. 
In addition, chromium did not significantly interact with 
vanadium. 
Chromium and Tissue and Bone Minerals 
Newer analytical methods and improved awareness of 
trace mineral contamination have contributed to increased 
accuracy of reported chromium concentrations (25). In 
humans, chromium concentrations decrease markedly within 
the first few months of life in lung, heart, and spleen 
tissues (25). Liver and kidney retain neonatal 
concentrations until 10 years of age. In areas where 
maturity-onset diabetes and atherosclerosis are high, 
tissue concentrations of chromium tend to be lower (25). 
In addition, Hunt et al. (95) observed significantly lower 
hair chromium concentrations in diabetic humans when 
compared to non-diabetics. 
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Chromium supplementation in humans has been observed 
to significantly increase serum chromium concentrations 
(96). Kidney and bone chromium concentrations increased in 
chromium-supplemented lean and obese mice; however, 
chromium tissue accumulation was greater in the bone and 
spleen tissues of obese mice than in lean mice (97). Liver 
chromium concentration was not affected by chromium 
supplementation. 
Donaldson et al. (92) observed lower liver and kidney 
chromium concentrations in rats fed low-chromium diets than 
in rats fed chromium-supplemented diets. However, only 
differences in kidney concentrations between rats fed low-
chromium or chromium-adequate diets reached statistical 
significance (92). 
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Shortened Title: 
TRACE MINERAL EFFECTS ON LIPIDS AND GLUCOSE 
ABSTRACT 
The effect(s) and interaction(s) of copper, zinc, and 
chromium on plasma lipids and glucose concentrations were 
evaluated with 72 male Japanese quail, Coturnix coturnix 
japonica, using a three-factor central composite response 
surface design. Quail were randomly assigned to one of 
fifteen experimental diets containing variable 
concentrations of copper (1.6 to 8.3 ugfq diet), zinc (11 
to 51 ugfg diet), and chromium (71 to 1124 ng/g diet). 
After six weeks, blood samples were collected by cardiac 
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puncture for plasma lipid and glucose analyses. No 
significant differences were observed for plasma total 
cholesterol, LDL-cholesterol, triglycerides, or glucose 
concentrations for the mineral ranges studied. However, 
chromium and copper had a significant interactive effect on 
increasing HDL-cholesterol (p<0.02). 
INDEXING KEY WORDS: Japanese quail, lipids, chromium, 
copper, zinc 
Cardiovascular disease is the leading cause of death 
in the United States (1), and hypercholesterolemia is 
considered to be a major contributing risk factor in the 
development of cardiovascular disease (2). Additionally, 
hypercholesterolemia is one of the top three modifiable 
factors related to cardiovascular disease (3). Substantial 
nutritional research has focused on dietary modifications 
to improve plasma lipid profiles and thus lower 
cardiovascular disease risk (4). 
Diets low in saturated fat and cholesterol, and 
increased exercise are beneficial in improving plasma 
lipids (5,6). However, other dietary factors including 
adequate trace minerals may also improve plasma lipids. 
This is of great importance because typical American diets 
often provide inadequate amounts of trace minerals (7). 
Low intakes of several minerals, including copper, zinc, 
and chromium have been implicated with abnormal lipid 
profiles (8-13). Thus, these minerals may have the 
potential for improving plasma lipids and thus lowering 
cardiovascular disease risk. 
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No conclusive benefits of copper, zinc, or chromium 
for hypercholesterolemia have been established. However, 
it is possible that the therapeutic potential of copper, 
zinc, and chromium in relationship to hypercholesterolemia 
may lay in the interrelationship of these or other trace 
minerals. In this study, response surface regression 
analysis was used to investigate the effect(s} andfor 
interaction(s} of copper, zinc, and chromium on plasma 
lipids and fasting glucose concentrations in male Japanese 
quail. 
MATERIALS AND METHODS 
Animals 
Japanese quail were the experimental animal model 
selected for this study. Rodent models are not the most 
suitable animal model for lipid studies because the rat has 
unusually high levels of high density lipoproteins (12}. 
The protocol for this study was reviewed and approved by 
the Oklahoma State University Institutional Animial Care 
and Use Committee. 
Two hundred hatchling Japanese quail (Coturnix 
coturnix japonica} (B and D Game Farms, Harra, OK} were 
held on a holding diet for four weeks until gender could be 
determined by feathering, at which time seventy-two male 
Japanese quail were weighed and randomly assigned to the 
experimental diets for six weeks. 
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The animals were housed in an isolated laboratory, in 
accordance with USDA and NIH guidelines for laboratory 
animals. The temperature and light-controlled laboratory 
was maintained by personnel from Laboratory Animal 
Resources in the College of Veterinary Medicine at Oklahoma 
State University. During the initial four week holding 
period animals were group housed in polystyrene cages with 
supplemental heat provided by heat lamps, with decreasing 
heat intensity. During the first week, 100 watt bulbs 
provided the heat; 75 watt bulbs supplied the heat in the 
second week and during the third and fourth weeks, 50 watt 
bulbs were used. During the experimental period animals 
were individually housed in polystyrene cages. Ceramic 
feed cups and water containers were used to reduce 
possibilities for mineral contamination. 
Japanese quail are a promising small animal model for 
lipid research (14-19). Japanese quail mature rapidly and 
are economical for animal studies with large numbers. 
Diets 
The experimental diets, vitamin and mineral mixes were 
formulated to contain all nutrients recommended by the 
National Research Council for growing Japanese quail (20) 
except for copper, zinc, and chromium as dictated by the 
experimental design (Table 1). Semi-purified diets, 
vitamin and mineral mixes were prepared in our laboratory 


























1vitamin mix formulated to meet the National Research 
Cou¥cil recommendations for growing Japanese quail. 
Mineral mix formulated to meet the National Research 
Council mineral recommendations for growing Japanese quail 
except for chromium, copper and zinc. 
The experimental mineral mixes for this study were 
based on a three factor central composite rotatable 
response surface design (21) (Table 2). Response surface 
analysis is a statistical technique which evaluates the 
interrelationship of two or three independent variables 
with a minimal sample size (21). 
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TABLE 2 
Zinc, copper, and chromium concentrations1 of experimental 
diets using a three-factor 
response surface design 

























( 1, 1, 1) 40.2 6.3 821 4 
(-1, 1, 1) 19.6 5.1 856 4 
( 1,-1, 1) 46.1 3.3 811 4 
( 1, 1, -1) 45.6 8.1 228 4 
(-1,-1, 1) 19.4 3.0 729 4 
(-1, 1,-1) 20.9 8.0 261 4 
( 1,-1,-1) 41.3 2.8 268 4 
(-1,-1,-1) 20.3 2.7 270 4 
( 1.68,0,0} 51.0 s.o 532 4 
(-1.68,0,0) 11.2 4.7 489 4 
(0,1.68,0) 30.5 8.3 485 4 
(0,-1.68,0) 31.4 1.6 488 4 
(0,0, 1.68) 30.5 4.5 1124 4 
(0,0,-1.68) 29.2 5.5 71 4 
(0,0,0) 28.7 5.7 465 16 
1As determined by atomic absorption spectrophotometry. 
2Response surface code. 
The ranges of copper, zinc, and chromium studied were; 
copper 1.6 ugfg diet to 8.3 ugfg diet, zinc 11 ugfg diet to 
51 ugfg diet, and chromium 71 ngfg diet to 1124 ngfg diet. 
The initial four week holding diet consisted of a 
moderately low mineral combination to prevent tissue 
mineral accumulation (Table 2). 
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The mineral mixes were prepared from reagent grade or 
ultrapure chemicals, after assaying each mineral lot 
number, because different lots have been found to vary 
widely. The experimental diets were analyzed for total 
mineral content before feeding. The experimental diets and 
deionized water were available ad libitum except as 
specified by the experimental design. 
Plasma Lipid and Glucose Analyses 
After six weeks on the experimental diets the quail 
were fasted for 12 hours prior to blood collection. 
Methoxyflurane was used for anesthesia. The birds were 
weighed and blood was collected by cardiac puncture into a 
heparinized, trace-mineral-free syringe and centrifuged to 
obtain plasma. One milliliter of plasma was chilled 
immediately and used for plasma total cholesterol and HDL-
cholesterol analyses using an enzymatic method (22). 
Plasma for triglycerides was frozen and analyzed using a 
microenzymatic procedure (23). Plasma LDL-cholesterol was 
determined by calculation using the equation LDL=TC-
(HDL+TG/5) (24). Plasma for glucose was frozen and 
analyzed using an enzymatic colorimetric procedure 
utilizing glucose oxidase (25,26). 
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Data Analyses 
Data were analyzed by the Statistical Analysis System 
(SAS) using the SAS response surface regression analysis 
(RSREG). This procedure allows the use of two or more 
independent variables to determine maximum and minimum 
responses of the dependent variables. In this study, 
response surface regression analyses were performed to find 
relative minimum response levels for plasma total 
cholesterol, LDL-cholesterol, triglycerides, and glucose, 
and a relative maximum response level for HDL-cholesterol 
at various levels of copper, zinc, and chromium. Response 
surface regression analyses produced regression equations 
for each of the dependent variables: total cholesterol, 
LDL-cholesterol, HDL-cholesterol, triglycerides, and 
glucose. Because of the complexity of the response surface 
analyses, two-dimensional response surface contour plots 
were produced for each of the dependent variables using 
RSREG. To graph the dependent variable response surface 
contours, the three variable regression equations were 
reduced to the most useful two variables by holding the 
third variable in the equation at the optimal value as 
determined by RSREG. These response surface contours can 
be used to determine dependent variable responses at 
various combinations of the independent variables. In 
interpreting the response surface contours, the lightest 
shading represents decreased dependent variable responses 
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while the darkest shading is indicative of higher dependent 
variable responses. The level of significance for this 
study was set at p <0.05. Probabilities are cited from the 
total regression model, unless otherwise specified. 
RESULTS 
No significant differences were observed in quail 
initial weights, final weights or weight gain between 
treatments. Initial body weights averaged 79 g, final body 
weights averaged 149 g, and weight gain averaged 70 g. 
No significant differences were observed for plasma 
total cholesterol, LDL-cholesterol, triglycerides, or 
glucose for the mineral ranges studied (Figures 1-4). 
However, chromium and copper had a significant linear 
interactive effect (p<0.02) on HDL-cholesterol (Figure 5), 
with HDL-cholesterol increasing as chromium and copper 
increased in the diet. 
DISCUSSION 
Although significant differences for total-cholesterol 
and LDL-cholesterol were not observed for the ranges 
studied, the data indicates a trend towards decreasing 
total cholesterol, LDL-cholesterol, triglycerides, and 
glucose at combined higher chromium and copper levels than 
were evaluated. The data also indicate a trend for HDL-
cholesterol continuing to increase at combined higher 
chromium and copper levels than were evaluated. 
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Most of the research addressing copper concentrations 
and lipid responses concentrates on copper depletion and 
deficiency (27-29). Copper deficiency has been observed to 
result in increased plasma total cholesterol, 
triglycerides, and LDL-cholesterol concentrations in rats 
(27-29). However, HDL-cholesterol concentrations only 
moderately increased with copper depletion and deficiency 
in rats (27-29). Figures 2 and 3 indicate that at combined 
higher levels of copper and chromium in the diet, the LDL-
cholesterol and triglyceride responses are beginning to 
decline. Railes and Albrink (30) observed that chromium 
supplementation increased HDL-cholesterol and decreased 
fasting blood glucose through increased insulin sensitivity 
in adult men. In the present study, HDL-cholesterol 
concentrations were significantly increased in quail fed 
diets with combined higher copper and chromium 
concentrations (Figure 5). However, at the lower copper, 
higher chromium diet combination HDL-cholesterol 
concentrations were reduced. Interactions between the 
minerals at minimal copper levels could negate the increase 
in HDL-cholesterol concentrations as seen in animals fed 
chromium-supplemented diets (30,31). Plasma glucose 
responded similarly in the Japanese quail with minimal 
glucose responses at the combined higher chromium, lower 
copper combination. Many researchers have observed 
improved glucose tolerance responses or improved plasma 
glucose values upon chromium supplementation (25,30,31). 
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Other researchers (32,33) have observed no significant 
changes in plasma glucose and lipid responses in subjects 
supplemented with chromium. Some researchers believe that 
only subjects with marginal chromium status respond to 
chromium supplementation (30). Additional research is 
needed on lipid and glucose responses in relation to trace 
mineral interactions. However, a hypothesis can be drawn 
from the present data that combined higher levels of 
chromium and copper will continue to improve lipid 
profiles, and that there may be an higher combination of 
chromium and copper which will provide optimal lipid 
profiles. 
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FIGURE 2 Digital contour plot of plasma 
LDL-cholesterol (mg/dl) as a function of 
copper and chromium in the diet with 
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FIGURE 3 Digital contour plot of plasma 
triqlycerides (mqfdl) as a function of 
copper and chromium in the diet with 
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FIGURE 4 Diqital contour plot of plasma 
qlucose (mq/dl) as a function of copper 
and chromium in the diet with zinc in 
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FIGURE 5 Digital contour plot of plasma 
HDL-cholesterol (mg/dl) as a function of 
copper and chromium in the diet with 





INDEPENDENT AND/OR INTERACTIVE EFFECT(S) OF COPPER, ZINC, 
AND CHROMIUM LEVELS ON BONE AND TISSUE MINERAL 
CONCENTRATIONS IN MALE JAPANESE QUAIL 
Nihiser, R.G., Hermann, J.R., Adeleye, B.O., 
Stoecker, B.J., Arquitt, A.B., 
and Brusewitz, G.H. 
Department of Nutritional Sciences, Oklahoma state 
University, Stillwater, Oklahoma 74078. 
Shortened Title: 
TRACE MINERAL EFFECTS ON BONE 
ABSTRACT 
The independent and/or interactive effect(s) of copper, 
zinc, and chromium levels on bone mineral concentrations, 
the maximum force required to fracture femurs, and tissue 
mineral concentrations were evaluated in 72 male Japanese 
quail, Coturnix coturnix japonica, using a three-factor 
central composite response surface design. Quail were 
randomly assigned to one of fifteen experimental diets 
containing variable concentrations of copper (1.6 to 8.3 
59 
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ugfg diet), zinc (11 to 51 ugfg diet), and chromium (71 to 
1124 ngfg diet). After six weeks on the experimental 
diets, the femurs, liver, and spleen were removed, weighed 
and frozen for mineral analyses and analyses of the maximum 
force required to fracture femurs. Dietary copper had a 
significant main effect (p<O.OS) on minimizing bone copper 
concentration and dietary zinc had a significant linear 
main effect (p<O.Ol) on minimizing bone magnesium 
concentration. Copper and zinc had a significant 
interactive effect on maximizing the force required to 
fracture femurs (p<O.OS). Copper had a significant 
quadratic effect on maximizing liver zinc and magnesium 
concentrations (p<O.OJ and p<O.Ol, respectively). Copper, 
zinc, and chromium all had significant effects on 
maximizing liver calcium (p<O.OS). Zinc had a significant 
effect on minimizing liver chromium (p<0.02), and copper 
had a significant effect on maximizing liver iron (p<O.OS) 
concentrations. 
INDEXING KEY WORDS: Japanese quail, chromium, copper, zinc, 
bone, 
Osteoporosis has become the most important bone 
disease in Western countries. osteoporosis afflicts 15 to 
20 million Americans, resulting each year in an estimated 
1.3 million fractures in individuals 45 years of age and 
older. One-third of women 65 years and older have 
vertebral fractures, and by age 90, one-third of women will 
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have hip fractures, leading to death in 12 to 20 percent of 
all cases and to long-term nursing home care for many 
survivors (1). 
Much of the research relative to nutrition has focused 
on low intakes of dietary calcium, vitamin D, fluoride, and 
boron as dietary factors affecting bone mineral 
concentrations (2,3). However, other dietary factors 
including trace minerals such as copper, zinc, and 
chromium, are related to bone loss and have an impact on 
bone mineral content (4-12). Zinc is an important factor 
in bone mineralization (1), and copper has been shown to 
inhibit bone resorption (1). This is of great importance 
because typical American diets often provide inadequate 
amounts of trace minerals (13). 
Thus, these minerals may have the potential for 
improving bone mineral concentrations and lowering risk of 
osteoporosis. In addition, the interaction of these trace 
minerals on bone mineral concentrations and the maximum 
force required to break femurs has not been investigated. 
In this study, response surface regression analysis was 
used to investigate the independent and/or interactive 
effect(s) of copper, zinc, and chromium levels on bone 
mineral concentrations, the maximum force required to break 
femurs, and liver and spleen mineral concentrations in male 
Japanese quail. 
MATERIALS AND METHODS 
Animals 
Japanese quail (Coturnix coturnix japonica) were the 
experimental animal model selected for this study. 
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Japanese quail have been established as an appropriate 
animal model for evaluating various osteoporotic factors 
(14, 15, 16). The protocol for this study was reviewed and 
approved by the Oklahoma State University Institutional 
Animal Care and Use Committee. 
Two hundred hatchling Japanese quail (B and D Game 
Farm, Harra, OK) were held on a holding diet for four weeks 
until gender could be determined by feathering, at which 
time seventy-two male Japanese quail were weighed and 
randomly assigned to the experimental diets for six weeks. 
The animals were housed in an isolated laboratory, in 
accordance with USDA and NIH guidelines for laboratory 
animals. The temperature and light-controlled laboratory 
was maintained by personnel from Laboratory Animal 
Resources in the College of Veterinary Medicine at Oklahoma 
state University. During the initial four week holding 
period animals were group housed in polystyrene cages with 
supplemental heat provided by heat lamps, with decreasing 
heat intensity. During the first week, 100 watt bulbs 
provided the heat; 75 watt bulbs supplied the heat in the 
second week and during the third and fourth weeks, 50 watt 
bulbs were used. During the experimental period animals 
were individually housed in polystyrene caqes. Ceramic 
feed cups and water containers were used to reduce 
possibilities for mineral contamination. 
Diets 
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The experimental diets, vitamin and mineral mixes were 
formulated to contain all nutrients recommended by the 
National Research council for qrowinq Japanese quail (17) 
except for copper, zinc, and chromium as dictated by the 
experimental desiqn (Table 1). Semi-purified diets, 
vitamin and mineral mixes were prepared in our laboratory 
after assayinq all components for trace mineral content. 
The experimental mineral mixes for this study were 
based on a three factor central composite rotatable 
response surface desiqn (18) (Table 2). Response surface 
analysis is a statistical technique which evaluates the 
interrelationship of two or three independent variables 
with a minimal sample size (18). The ranqes of copper, 
zinc, and chromium studied were; copper 1.6 uqfq diet to 
8.3 uqfq diet, zinc 11 uqfq diet to 51 uqfq diet, and 
chromium 71 nqfq diet to 1124 nqfq diet. The initial four 
week holdinq diet consisted of a moderately low mineral 



























1vitamin mix formulated to meet the National Research 
Cou2cil recommendations for growing Japanese quail. 
Mineral mix formulated to meet the National Research 
Council mineral recommendations for growing Japanese quail 
except for chromium, copper and zinc. 
The mineral mixes were prepared from reagent grade or 
ultrapure chemicals, after assaying each lot number of 
minerals, as different lots have been found to vary widely. 
The experimental diets were analyzed for total mineral 
content before feeding. The experimental diets and 
deionized water were available ad libitum except as 
specified by the experimental design. 
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TABLE 2 
Zinc, copper, and chromium concentrations1 of experimental 
diets using a three-factor 
Diet RS Code2 
(Zn,cu,Cr} 





Holding(-1,-1,-1.68} 19.3 3.1 
1 ( 1, 1, 1} 40.2 6.3 
2 (-1, 1, 1) 19.6 5.1 
3 ( 1,-1, 1} 46.1 3.3 
4 ( 1, 1, -1} 45.6 8.1 
5 (-1 -1 I I 1) 19.4 3.0 
6 (-1, 1,-1) 20.9 8.0 
7 ( 1,-1,-1) 41.3 2.8 
8 (-1,-1,-1) 20.3 2.7 
9 ( 1.68,0,0) 51.0 5.0 
10 (-1.68,0,0) 11.2 4.7 
11 (0,1.68,0) 30.5 8.3 
12 (0,-1.68,0) 31.4 1.6 
13 (0,0, 1.68) 30.5 4.5 
14 (0,0,-1.68) 29.2 5.5 



































1As determined by atomic absorption spectrophotometry. 
2Response surface code. 
Necropsy 
After six weeks on the experimental diets the quail 
were fasted for 12 hours prior to necropsy. Methoxyflurane 
was used for anesthesia. The birds were weighed and the 
liver and spleen were removed carefully to avoid chromium 
contamination, weighed, and frozen separately for tissue 
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mineral analyses. Both femurs were removed, cleaned with a 
glass knife and separately weighed into acid-washed 
borosilicate glass tubes under a clean air hood to avoid 
mineral contamination and frozen for bone mineral analyses 
and maximum force required to break femurs. 
Tissue and Bone Mineral Analyses 
For tissue mineral analyses, tissues were sampled (250 
- 500 mg) using a glass knife under a clean air hood. 
Samples were weighed into acid-washed borosilicate glass 
tubes and dried for 24 h at 100°C. Samples were then ashed 
in a muffle furnace with no exposed metal heating elements 
(Lindberg, Watertown, WI) using a modified wet-dry ashing 
procedure (12,19). After ashing, samples were diluted with 
1N HCl (G. Fredrick Smith, Columbus, OH) and analyzed at 
324.8 nm for copper, 213 nm for zinc, and 357.9 nm for 
chromium using a Perkin Elmer Model 5000 atomic absorption 
spectrophotometer with flame and graphite furnace and 
Zeeman background correction (Perkin Elmer Corp., Norwalk, 
CT.). Tissue chromium and bone copper were analyzed on the 
graphite furnace and all other mineral analyses were 
performed on the flame furnace. Drying and ashing 
procedures for bone analyses were similar to tissue 
analyses, however, repetition of the steps was required. 
Maximum Force To Break Femur Analyses 
The force required to break femurs was measured on a 
three point bending fixture with an Instron Universal 
Testing Machine at a loading rate of 1 mm/minute. 
Data Analyses 
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Data were analyzed by the Statistical Analysis System 
(SAS) using the SAS response surface regression analysis 
(RSREG). This procedure allows the use of two or more 
independent variables to determine maximum and minimum 
responses of the dependent variables. In this study, 
response surface regression analyses were performed to find 
response levels for the maximum force required to fracture 
femurs, and bone and tissue minerals at various levels of 
copper, zinc, and chromium. Response surface regression 
analyses produced regression equations for each dependent 
variable. Because of the complexity of the response 
surface analyses, two-dimensional response surface contour 
plots were produced for each of the dependent variables 
using RSREG. To graph the dependent variable response 
surface contours, the three variable regression equations 
were reduced to the most useful two variables by holding 
the third variable in the equation at the optimal value as 
dete~ined by RSREG. These response surface contours can 
be used to determine dependent variable responses at 
various combinations of the independent variables. In 
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interpreting the response surface contours, the lightest 
shading represents decreased dependent variable responses 
while the darkest shading is indicative of higher dependent 
variable responses. The level of significance for this 
study was set at p < 0.05. Probabilities are cited from 
the total regression model unless otherwise specified. 
RESULTS 
Dietary copper had a significant main effect (p<0.05) 
on minimizing bone copper concentration (Figure 1). 
Although not significant, dietary copper and zinc had an 
quadratic effect (p=0.056) on minimizing bone calcium 
concentration (Figure 2). Dietary zinc had a significant 
linear main effect (p<O.Ol) on minimizing bone magnesium 
concentration (Figure 3). Copper and zinc had a 
significant interactive effect (p<0.05) on maximizing the 
force required to break femurs (Figure 4). The region 
where combined copper and zinc increased the force required 
to break femurs was above the regions where other bone 
mineral concentrations were minimized. Though not 
significant, chromium also had a positive effect on the 
maximum force required to break femurs (p=0.058). No 
significant effect was observed for bone zinc or iron 
concentrations; however, there was a strong trend for 
minimization of bone zinc within the mineral ranges 
investigated in this study (Figure 5). 
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Copper had a significant quadratic effect on 
maximizing liver zinc (Figure 6) and magnesium (Figure 7) 
concentrations, (p<O.OJ and p<0.01), respectively. 
Chromium, copper and zinc all had a significant effect 
(p<0.05), and copper and chromium had a significant 
interactive effect (p<0.001) on maximizing liver calcium 
(Figure 8). Zinc had a significant effect on minimizing 
liver chromium (p<0.02) (Figure 9), and copper had a 
significant effect on maximizing liver iron (p<0.05) 
(Figure 10) concentrations. No significant effect was 
observed for liver copper concentration; however, there was 
a trend for maximizing liver copper within the mineral 
ranges investigated in this study (Figure 11). 
Additionally, copper had a significant quadratic main 
effect on minimizing spleen copper (p<0.05) (Figure 12). 
No significant effect was observed for spleen chromium and 
zinc concentrations; however, there was a trend for 
maximizing spleen chromium and minimizing spleen zinc 
within the mineral ranges investigated in this study 
(Figure 13 and 14, respectively). 
DISCUSSION 
Several studies have investigated the effect of 
excessive or inadequate trace mineral intakes on bone 
structure and composition. Ledoux and colleagues (10) 
observed that an inadequate copper intake resulted in 
decreased bone copper concentrations in chicks. In our 
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study, we observed that as copper increased in the diet 
there was a quadratic response on bone copper concentration 
(Figure 1). This indicates that at suboptimal levels, the 
bone may serve as a copper reservoir and as intakes 
increase beyond suboptimal levels, copper deposition begins 
to occur. Several studies have reported that deficient 
dietary zinc intake resulted in decreased bone zinc 
concentrations (S-9). In our study we did not observe a 
significant effect of dietary zinc on bone zinc. However, 
there appeared to be a trend for minimizing bone zinc at 
lower dietary levels (Figure 5). Like copper, dietary zinc 
also affected other bone minerals. Dietary zinc had a 
significant linear effect on minimizing bone magnesium 
(Figure 3). Additionally, copper and zinc had an 
interactive effect on bone calcium and on the force 
required to fracture femurs (Figures 2 and 4). Thus, our 
research indicates that dietary copper and zinc not only 
affect bone copper and zinc minerals but also independently 
and interactively affect other bone mineral concentrations. 
Several researchers have reported that liver copper 
concentrations decrease with copper deficiency (20-23). In 
the present study, although not significant, there was a 
quadratic response with liver copper concentrations as 
dietary copper increased. Additionally, liver zinc 
concentrations have been correlated with liver copper (24). 
We also observed a significant quadratic effect of dietary 
copper on maximizing liver zinc, as well as on liver 
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magnesium, and iron. In addition, copper and chromium had 
a significant interactive effect on maximizing liver 
calcium. Thus, it appears that dietary copper may have a 
significant effect on maximizing many other trace elements. 
Numerous researchers have reported that liver zinc 
concentrations decrease with deficient zinc intake (25-28) 
and that liver zinc concentrations increase with zinc 
supplementation (29). Although not significant, we also 
observed an increase in liver zinc with increasing dietary 
zinc. In addition, we observed a significant effect of 
dietary zinc on minimizing liver chromium. It has been 
reported that zinc influences chromium absorption; more 
specifically that zinc decreased chromium absorption while 
chromium decreased zinc absorption in zinc-deficient rats 
(30). The present results do not demonstrate that dietary 
chromium has a significant effect on liver chromium. 
Additionally, Seaborn and Stoecker (12) have reported that 
liver chromium concentration in mice was not affected by 
dietary chromium. 
Thus, it appears that the dietary intake of trace 
minerals not only affects bone and tissue mineral 
concentrations of those minerals being varied, but also 
bone and tissue concentrations of other minerals. In 
addition, the interactive effects of trace minerals also 
influence various bone and tissue mineral concentrations. 
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FIGURE 1 Digital contour plot of bone 
copper (ng/g dry weight) as a function of 
zinc and copper in the diet with chromium 
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FIGURE 2 Diqital contour plot of bone 
calcium (uqfq dry weiqht) as a function 
of zinc and copper in the diet with 
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FIGURE 3 Digital contour plot of bone 
magnesium (ugjg dry weight) as a function 
of zinc and copper in the diet with 
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FIGURE 4 Digital contour plot of femur 
fracture force as a function of zinc 
and copper in the diet with chromium 
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FIGURE 5 Diqital contour plot of bone zinc (uq/q 
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FIGURE 6 Digital contour plot of liver zinc 
(ugfg dry weight) as a function of zinc and 
copper in the diet with chromium in the 
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FIGURE 7 Digital contour plot of liver magnesium 
(ugfg ~ weight) as a function of zinc and 
copper 1n the diet with chromium in the 
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FIGURE 8 Digital contour plot of liver calcium 
(ugfg dry weight) as a function of zinc and 
copper in the diet with chromium 
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FIGURE 9 Diqital contour plot of liver chromium 
(nqfq d~ weiqht) as a function of zinc and 
copper 1n the diet with chromium 
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FIGURE 10 Digital contour plot of liver iron 
(ugfg dry weight) as a function of zinc and 
copper in the diet with chromium in 
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FIGURE 11 Digital contour plot of liver copper 
(uqfq dry weiqht) as a function of zinc and 
copper in the diet with chromium in 
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FIGURE 12 Diqital contour plot of spleen copper 
(uqfq dry weiqht) as a function of zinc and 
copper in the diet with chromium set in 
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FIGURE 14 Digital contour plot of spleen zinc 
(ngfg dry weight) as a function of zinc and 
copper in the diet with chromium in 
the diet set at 584 ngfg. 
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CHAPTER V 
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS 
Summary 
This research evaluated the independent andjor 
interactive effect(s) of copper, zinc, andjor chromium on 
plasma lipids and glucose, in male Japanese quail. In 
addition, this study evaluated the independent andjor 
interactive effect(s) of these minerals on tissue and bone 
mineral concentrations, as well as the maximum force 
required to fracture femurs in male Japanese quail. 
Four hypotheses were listed in the introduction of 
this thesis. The first hypothesis stated that there would 
be no statistically significant independent and/or 
interactive effect(s) of copper, zinc andjor chromium on 
plasma lipids (total cholesterol, LDL-cholesterol, HDL-
cholesterol, and triglycerides) in male Japanese quail. 
The second hypothesis stated that there would be no 
statistically significant independent andjor interactive 
effect(s) of copper, zinc, andjor chromium on plasma 
glucose in male Japanese quail. No significant differences 
were observed for plasma total cholesterol, LDL-
cholesterol, triglycerides, or glucose between dietary 
treatments for the mineral ranges studied. However, a 
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significant linear effect was observed for HDL-cholesterol 
as a response to copper and chromium (p<0.02) after six 
weeks, with HDL-cholesterol increasing as both copper and 
chromium increased in the diet. Therefore, based on these 
results the first null hypothesis is rejected and we fail 
to reject the second null hypothesis. 
Hypothesis three stated that there would be no 
statistically significant independent and/or interactive 
effect(s) of copper, zinc, and/or chromium on liver, 
spleen, and bone mineral concentrations in male Japanese 
quail. After six weeks, dietary copper had a significant 
main effect on bone copper (p<O.OS). Dietary zinc had a 
significant linear main effect (p<O.Ol) on bone magnesium. 
Copper had a significant quadratic effect on liver zinc and 
magnesium concentrations (p<0.03), and copper, zinc, and 
chromium all had significant effects on liver calcium 
(p<O.OS), and there was a significant interactive effect 
between copper and chromium (p<O.OOl) on liver calcium. 
Zinc also had a significant effect on liver chromium 
(p<0.02), and copper had a significant effect on liver iron 
(p<O.OS) concentrations. Additionally, copper had a 
significant quadratic main effect on spleen copper 
(p<O.OS). Therefore, based on these results the third null 
hypothesis is rejected. 
Hypothesis four stated that there would be no 
statistically significant independent and/or interactive 
effect(s) of copper, zinc, and/or chromium on the maximum 
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force required to fracture femurs in male Japanese quail. 
At six weeks, copper and zinc had a significant interactive 
effect on the force required to fracture femurs (p<0.05). 
Therefore, based on these results the fourth null 
hypothesis is rejected. 
Conclusions 
Copper and chromium were the most significant 
variables in terms of their effect on blood lipids. 
Although plasma HDL-cholesterol was the only lipid response 
that was significant, higher dietary copper and chromium 
concentrations may further influence plasma LDL-
cholesterol, total-cholesterol, triglyceride, and glucose 
responses. Plasma LDL-cholesterol concentration began to 
decline at the highest chromium and copper combinations in 
this study. This may indicate that higher chromium and 
copper combinations may be beneficial in further reducing 
LDL-cholesterol concentrations. Plasma triglyceride 
concentrations were beginning to minimize at the higher 
concentrations of copper and chromium in this study. 
Plasma total-cholesterol, maximizing at higher combined 
concentrations of dietary copper and chromium, may reflect 
an overlap of the maximum response of plasma HDL-
cholesterol. Plasma glucose responses also were beginning 
to minimize at higher combined concentrations of copper and 
chromium. An overall conclusion that can be drawn from 
these trends is that combined higher concentrations of 
92 
copper and chromium could elicit optimal lipid responses in 
Japanese quail. 
It is the mineral combinations of dietary zinc and 
copper, however, that predominantly influenced bone and 
tissue mineral concentrations as seen by the significant 
·effects on bone copper, magnesium, and calcium as well as 
the significant effects on liver zinc, magnesium, calcium, 
and iron, and on spleen copper. There was also a 
significant interactive effect between dietary zinc and 
copper on the maximum force required to fracture femurs. 
Therefore, zinc and copper are important dietary factors 
affecting bone and tissue mineral concentrations as well as 
the maximum force required to break femurs. In addition, 
this research indicates that dietary zinc and copper not 
only influence the zinc and copper concentrations in the 
bone and tissues, but these minerals also independently and 
interactively affect other bone and tissue mineral 
concentrations, such as magnesium, calcium, and iron. 
Recommendations 
Trace mineral research and data using Japanese quail 
as the animal model are limited. Future research verifying 
the present data and exploring the various responses would 
be beneficial. 
The plasma lipid parameters, although not all 
significantly, responded to the higher dietary 
concentrations of copper and chromium. Exploration of the 
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plasma lipid and glucose responses of Japanese quail at 
combined higher concentrations of copper and chromium, 
which surpass the scope of mineral concentrations examined 
in the present study, is recommended. 
In addition, the dietary mineral ranges examined in 
this study significantly influenced several bone and tissue 
minerals. Future research looking at the different mineral 
concentrations and the corresponding influence on bone 
strength could provide valuable information. 
Lastly, exploring the influence of trace minerals, 
within safe and adequate ranges, on plasma lipids and 
minerals in humans could prove to be very informative. Not 
only are trace minerals low in typical American diets, but 
improving lipid profiles and bone strength are pertinent 
health issues for many Americans. Therefore, similar 
studies investigating dietary trace minerals and their 
effects on lipid profiles and bone metabolic enzymes would 
be beneficial. 
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